Tiredness is listed as a very common side effect of Wegovy in the UK prescribing information, meaning it affects more than 1 in 10 people, and the SmPC records it as mainly seen during dose escalation.[1] Headache and nausea are also very common.[1] The documents do not describe a separate ‘day-after’ syndrome, and none of the sources reviewed tests injection time of day, pre-injection meals or electrolyte drinks as ways to prevent next-day symptoms. What they do establish is that Wegovy can be injected at any time of day, with or without food,[1][2][3] that vomiting and diarrhoea can cause dehydration so enough fluids matter,[1][2] and that the NHS advises against alcohol because it can worsen sickness.[3] Side effects that bother you are a reason to talk to a pharmacist or prescriber rather than adjusting treatment on your own.[3]
Key clinical fact
Fatigue and headache are very common
Both are listed as very common (more than 1 in 10 people) and mainly seen during dose escalation.[1]
Dosage and administration
Any time of day, with or without food
Wegovy is injected once a week. The day can be changed if at least 3 days have passed since the last injection.[1][2]
Evidence limitation
No tested ‘day-after’ fixes
No source reviewed tests evening injection, pre-injection meals or electrolyte drinks against next-day symptoms.
What the UK documents say about tiredness, headache and nausea
The SmPC lists adverse reactions by how often they occur. In the ‘very common’ group, affecting more than 1 in 10 people, are nausea, vomiting, diarrhoea, constipation, abdominal pain, headache and fatigue.[1] The patient leaflet describes the tiredness as feeling weak or tired and says these very common effects usually go away over time.[2] The NHS lists feeling tired among the common side effects of semaglutide.[3]
| Side effect | SmPC frequency | Mainly seen during dose escalation? | 68-week adult trials, 2.4 mg vs placebo (SmPC) |
|---|---|---|---|
| Nausea | Very common | Yes | 43.9% vs 16.1% |
| Vomiting | Very common | Yes | 24.5% vs 6.3% |
| Diarrhoea | Very common | Yes | 29.7% vs 15.9% |
| Constipation | Very common | Yes | 24.2% vs 11.1% |
| Headache | Very common | Yes | Not stated in the SmPC text |
| Fatigue | Very common | Yes | Not stated in the SmPC text |
| Abdominal pain | Very common | Yes | Not stated in the SmPC text |
| Dizziness | Common | Yes | Not stated in the SmPC text |
Source for the table: SmPC section 4.8.[1] The percentages describe groups of adults in trials lasting 68 weeks at the 2.4 mg dose. They are not a prediction for an individual. The placebo column matters because it shows that these symptoms also occurred without the active medicine, though at lower rates. The SmPC adds that most gastrointestinal events were mild to moderate and of short duration, and that they led to permanent discontinuation in 4.3% of patients.[1]
Is there a recognised ‘Wegovy hangover’?
‘Hangover’ is an informal description, not a diagnosis. None of the documents reviewed define a day-after syndrome, say how common it is or give its duration. The symptoms people describe, such as tiredness, nausea and headache, are each listed side effects, so a cluster of them after an injection is consistent with the product information. Consistent with is not the same as shown to be caused by the timing of the injection.
Why might symptoms follow an injection? The SmPC states that semaglutide has a half-life of around one week, which is why weekly dosing works, and that it remains in the circulation for approximately 7 weeks after the last 2.4 mg dose.[1] A long half-life works like a slowly draining bath: the medicine leaves the body gradually, over weeks, rather than vanishing between injections. The SmPC does not give a day-by-day symptom profile or a time to peak concentration for Wegovy. Explanations that rely on a drug-level peak soon after injection are therefore plausible mechanisms but are unproven for symptoms, and should be read as theory rather than established fact.
How long do individual episodes last?
A published pooled analysis of the STEP 1 to 3 trials found that most gastrointestinal adverse events were non-serious, mild to moderate and transient, and occurred most often during or shortly after dose escalation. Individual episodes were short: the median duration of nausea was 8 days, diarrhoea 3 days and vomiting 2 days, similar to placebo, and the prevalence of these events peaked at about week 20 before declining.[4] These figures concern gastrointestinal episodes in trial participants. They do not measure tiredness, and they do not describe a 24 to 48 hour window after each injection.
Dose escalation matters more than the time of day
The SmPC says the dose is escalated over 16 weeks to reduce the likelihood of gastrointestinal symptoms.[1] The licensed schedule is shown below. It is the prescribed schedule, not a target to reach faster.
| Treatment weeks | Weekly dose (licensed schedule) |
|---|---|
| 1 to 4 | 0.25 mg |
| 5 to 8 | 0.5 mg |
| 9 to 12 | 1 mg |
| 13 to 16 | 1.7 mg |
| From week 17 | 2.4 mg maintenance dose |
Source for the table: SmPC section 4.2, Table 2.[1] A higher 7.2 mg dose can be used in some adults with obesity after at least 4 weeks on 2.4 mg, and is outside the scope of this article.[1]
The same SmPC marks most of the common symptoms as mainly occurring in the dose-escalation period.[1] It also tells clinicians that, in the case of significant gastrointestinal symptoms, they may consider delaying dose escalation or lowering to the previous dose until symptoms improve.[1] That is a prescriber’s decision, made with the whole clinical picture. The patient leaflet tells people to use the medicine exactly as their doctor has told them and not to stop without talking to their doctor.[2]
Morning or evening, with or without food?
The SmPC states that Wegovy is given once weekly at any time of the day, with or without meals. The patient leaflet and the NHS give the same message.[1][2][3] The leaflet adds that the injection should be on the same day each week if possible.[2]
Injecting in the evening so that any symptoms fall during sleep is an understandable idea. However, none of the sources reviewed tests whether evening injection reduces next-day symptoms. The product information permits any time of day but does not say that one time is better. A person who injects at night and still feels unwell the next day cannot conclude from these documents that a morning injection would have been different, or the reverse.
What to eat before the injection
The documents give no pre-injection meal advice. The leaflet says Wegovy should be used with a reduced-calorie meal plan and increased physical activity,[2] and the NHS says to eat a healthy, balanced diet while using semaglutide.[3] No trial or guideline reviewed shows that a particular meal the night before prevents next-day nausea or tiredness. Because the product information places no restriction on food around the injection, any pre-injection eating pattern is a matter of personal preference. The NHS advice for side effects that bother you or do not go away is to speak to a pharmacist or doctor, who may be able to advise on reducing them.[3]
Fluids, dehydration and electrolyte drinks
Dehydration is the documented link between gastrointestinal side effects and feeling unwell. The SmPC says nausea, vomiting and diarrhoea may cause dehydration, which in rare cases can lead to a deterioration of kidney function, and that patients should be advised to take precautions to avoid fluid depletion.[1] The leaflet says it is important to drink enough fluids, especially for people with kidney problems.[2]
Neither document recommends electrolyte drinks, oral rehydration products or any particular fluid, and no trial reviewed tests them for injection-related tiredness. That leaves a gap. Dehydration is a documented risk of gastrointestinal side effects, but whether mild dehydration is what drives day-after tiredness in a given person has not been tested, so that link remains theoretical. People with kidney problems, which the leaflet flags as a particular concern, should ask a pharmacist or prescriber about fluids rather than rely on general advice.
Alcohol
The NHS says it is best not to drink alcohol while using semaglutide because it can increase side effects such as feeling or being sick.[3] Alcohol is therefore a documented way to add to nausea around an injection.
Other explanations to keep in mind
Tiredness is not specific to Wegovy. The leaflet lists low blood sugar (hypoglycaemia), with warning signs that include feeling sleepy or weak. It is common in people with diabetes who use Wegovy, more likely when taken with insulin or a sulfonylurea, and uncommon in people without diabetes.[2] Feeling dizzy is common, and dizziness or light-headedness on standing, caused by low blood pressure, is uncommon.[2]
Wegovy also reduces appetite,[2] and eating less could plausibly contribute to tiredness, but the documents reviewed do not assess that link. Tiredness that lasts beyond the early weeks, worsens, or comes with other symptoms deserves review by a prescriber, because tiredness has many causes unrelated to medicines.
Patient safety and when to seek assessment
- Severe, persistent pain in the stomach area, with or without nausea and vomiting, could signal acute pancreatitis. The leaflet says to stop using the medicine and seek urgent medical help.[2]
- Ongoing vomiting or diarrhoea can cause dehydration, which the SmPC says may rarely worsen kidney function. Raise it promptly with a prescriber or pharmacist, particularly if you have kidney problems.[1][2]
- Sudden loss of vision, or rapidly worsening eyesight, needs urgent contact with a doctor.[2]
- Breathing problems, or swelling of the face, lips, tongue or throat, could signal a severe allergic reaction and need immediate medical help.[2]
- Low blood sugar signs include cold sweat, shaking, confusion and feeling sleepy or weak. This is more likely with insulin or a sulfonylurea, and a doctor will advise on treatment.[2]
- If you feel dizzy or have vision problems, the NHS says not to drive, ride a bike or use machinery until the symptoms have gone.[3]
Frequently asked questions
How long does tiredness after a Wegovy injection last?
No source reviewed gives a duration for post-injection tiredness. The leaflet says very common side effects such as feeling weak or tired usually go away over time,[2] and the SmPC reports most gastrointestinal events as mild to moderate and short-lived.[1] The pooled trial analysis gives median durations for nausea, diarrhoea and vomiting, not for fatigue.[4] Tiredness that persists is a reason to speak to a pharmacist or doctor.[3]
Should I skip or delay an injection if I feel unwell the day after?
The documents do not tell patients to skip a dose because of tiredness. Delaying escalation or reducing the dose for significant gastrointestinal symptoms is described as a consideration for clinicians.[1] The only patient-facing rules cover a forgotten dose, which can be taken within 5 days of the missed day or skipped if later, with no double dose,[2][3] and changing the weekly day, which needs at least 3 days since the last injection.[2] Ask your prescriber before changing how you take it.
Is it safe to drive if I feel tired or dizzy after an injection?
The leaflet says some people feel dizzy, mainly during the first 3 months, and that you should not drive or operate machines until you feel better.[2] The NHS gives the same advice for dizziness or vision problems and also covers cycling.[3] The documents do not set a safe tiredness threshold for driving, so the decision rests on how alert you actually feel.
Editorial summary
The evidence establishes that tiredness, headache and nausea are very common, listed side effects of Wegovy, mainly during dose escalation, and that the medicine can be injected at any time of day with or without food. It also establishes that vomiting and diarrhoea carry a dehydration risk and that the NHS advises against alcohol.
What remains uncertain is whether a distinct day-after pattern exists, why it would occur, and whether evening dosing, particular meals or electrolyte drinks change it. No source reviewed tests these, and claims that they work are unsupported. The practical significance is to follow the label on fluids and alcohol, treat the early dose steps as the period when symptoms are most likely, and take persistent or severe symptoms to a pharmacist or prescriber instead of adjusting the dose yourself.
Statutory and Academic References
- Electronic Medicines Compendium (emc), Novo Nordisk Limited. Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen – Summary of Product Characteristics (SmPC). Last updated on emc 22 Sep 2026. Accessed 31 October 2026.
- Electronic Medicines Compendium (emc), Novo Nordisk Limited. Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen – Patient Information Leaflet (PIL). Leaflet last revised 08/2026; emc page last updated 22 Sep 2026. Accessed 31 October 2026.
- NHS. Semaglutide: a medicine to manage type 2 diabetes or treat obesity. Page last reviewed 15 May 2026; next review due 15 May 2029. Accessed 31 October 2026.
- Wharton S, et al. Diabetes, Obesity and Metabolism (2022), PubMed Central. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss (doi:10.1111/dom.14551). Published 2022. Accessed 31 October 2026.
- GOV.UK (Medicines and Healthcare products Regulatory Agency, Yellow Card Scheme). Report a problem with a medicine or medical device. Current GOV.UK service page. Accessed 31 October 2026.
Clinical & Regulatory Disclaimer
The content published on Vetted Therapeutics is provided for educational and informational purposes only. It does not constitute medical diagnosis, individualised treatment advice or clinical prescribing. Information is based on available published research and relevant regulatory or clinical guidance, subject to the limitations of the cited evidence. Vetted Therapeutics does not sell, distribute or endorse commercial medicines or products. Always seek appropriate advice from a qualified healthcare professional before making decisions about prescription medicines or treatment. For urgent medical concerns in the UK, contact NHS 111; in a life-threatening emergency, call 999.